Cervical HPV DNA at baseline
| | | | |
HPV-6 positive, yes vs. no
| | | | |
Effect in 1st year of follow-up
|
4/17
|
8.67 (1.86-40.40)
|
9.09 (1.75-47.29)
|
0.009
|
Effect after 1st year of follow-up
|
1/12
|
0.12 (0.03-0.54)
|
0.11 (0.02-0.57)
|
0.009
|
HPV-11 positive, yes vs. no
|
1/21
|
0.74 (0.07-7.58)
|
1.17 (0.11-12.37)
|
0.89
|
HPV-52 positive, yes vs. no
|
9/50
|
3.73 (1.28-10.83)
|
3.81 (0.90-16.23)
|
0.07
|
Other HPV types, negative for types 6, 11,52
|
19/226
|
1.48 (0.64-3.45)
|
2.64 (0.62-11.33)
|
0.19
|
Cervical cytology at baseline (N = 296)
| | | | |
Normal
|
9/369
|
1.0
|
1.0
| |
ASCUS/LSIL/HSIL
|
23/134
|
7.38 (3.10-17.56)
|
3.05 (1.17-7.92)
|
0.02
|
HIV status, nadir CD4+ count
| | | | |
HIV seronegative
|
4/289
| |
1.0
| |
HIV-1+, CD4 >200cells/μL
|
11/119
| |
3.22 (0.71-14.59)
|
0.13
|
HIV-1+, CD4 ≤200 cells/μL
|
18/79
| |
10.94 (2.60-46.12)
|
0.001
|